Statera Biopharma, Inc. — Form D

Statera Biopharma, Inc. of Fort Collins, CO, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-07. The offering totals $765K, of which $577K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (56)

Showing 25 of 56 people.

NameRoleLocation
Satish Kevin ChandrenDirectorFort Collins, CO
Michael Kevin HandleyDirectorFort Collins, CO
Blake Kevin HawleyDirectorFort Collins, CO
John Kevin KallassyDirectorFort Collins, CO
Uday Kevin SaxenaDirectorFort Collins, CO
Robert Kevin BuckheitExecutive OfficerFort Collins, CO
Michael Kevin HandleyExecutive OfficerFort Collins, CO
Christopher Kevin ZoshExecutive OfficerFort Collins, CO
Michael Kevin HandleyPromoterFort Collins, CO
Yakov KoganDirectorSalt Lake City, UT
Yakov KoganExecutive OfficerSalt Lake City, UT
Richard S McGowanDirectorWESTMINSTER, MA
Daniel PerezDirectorSan Francisco, CA
Alexander S AndryushechkinDirectorBuffalo, NY
Andrei S Gudkov, Ph.D., D., Sci.Executive OfficerBuffalo, NY
Langdon S Miller, MDExecutive OfficerBuffalo, NY
Lea S VernyDirectorBuffalo, NY
Christopher ZoshExecutive OfficerBuffalo, NY
Daniil S TalyanskiyDirectorBuffalo, NY
Anna S EvdokimovaDirectorBuffalo, NY
Ivan S FedyuninDirectorBuffalo, NY
Michael FonsteinDirectorWestport, CT
Michael FonsteinExecutive OfficerWestport, CT
Anna Neil EvdokimovaDirectorBuffalo, NY
Randy S SaluckDirectorBuffalo, NY

Other filings by this issuer (6)

FiledFormOfferingSold
2020-06-04D$1.6M$1.6M
2015-12-23D$1.1M$1.1M
2015-07-16D$25.0M$25.0M
2014-07-03D$3.5M$3.5M
2010-03-05D$5.0M$5.0M
2009-04-03D$3.7M$3.7M

More